General Information of Drug (ID: DMI42MN)

Drug Name
Carbon dioxide intranasal
Indication
Disease Entry ICD 11 Status REF
Trigeminal neuralgia 8B82.0 Phase 2 [1]
Cross-matching ID
TTD ID
D0G0GP

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)